ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ZURA Zura Bio Ltd

4.26
0.11 (2.65%)
Última actualización: 11:45:20
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Zura Bio Ltd ZURA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.11 2.65% 4.26 11:45:20
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.22 4.12 4.34 4.15
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202408:22BWZura Bio Announces Oversubscribed $112.5 Million Private..
08/4/202405:00BWZura Bio Announces Robert Lisicki as CEO and Director
28/3/202405:00BWZura Bio Reports Full Year 2023 Financial Results, Business..
04/3/202405:00BWZura Bio Announces Participation at March Conferences
23/2/202415:30EDGAR2Form 8-K - Current report
14/2/202408:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202405:00BWZura Bio Announces Participation at February Investor..
26/1/202410:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202410:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202410:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202416:25EDGAR2Form 8-K - Current report
08/1/202405:03EDGAR2Form 8-K - Current report
08/1/202405:00BWZura Bio Continues to Strengthen Leadership with Appointment..
03/1/202405:04EDGAR2Form 8-K - Current report
03/1/202405:00BWZura Bio to Present at the 42nd Annual J.P. Morgan..
04/12/202305:00BWZura Bio Announces Two Immunology Abstracts Presented at the..
17/11/202316:53EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/11/202305:00BWZura Bio Appoints Arnout Ploos van Amstel to its Board of..
13/11/202305:30BWZura Bio Reports Third Quarter 2023 Financial Results and..
25/10/202315:30EDGAR2Form 8-K - Current report
02/10/202320:30EDGAR2Form 8-K - Current report
14/9/202316:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/9/202315:23EDGAR2Form 8-K - Current report
12/9/202304:00BWZura Bio Enters into Sponsored Research Agreement with..
24/8/202320:54EDGAR2Form S-1/A - General form for registration of securities..
14/8/202306:00BWZura Bio Reports Second Quarter 2023 Financial Results and..
11/8/202316:13EDGAR2Form S-1/A - General form for registration of securities..
27/7/202316:07EDGAR2Form 8-K - Current report
21/7/202316:28EDGAR2Form S-1/A - General form for registration of securities..
23/6/202305:30BWZura Bio to Join the Russell 2000® and Russell 3000® Indexes
06/6/202303:00BWZura Bio Completes Approximately $80 Million Financing with..

Su Consulta Reciente

Delayed Upgrade Clock